Knowing early, safely.
iGene® NIPT tests for Down Syndrome and other chromosomal abnormalities and can be done with a simple blood draw from the mother, from ten weeks gestation.
What is iGene® NIPT?
iGene® Non-Invasive Prenatal Test (NIPT) that analyses cell-free fetal DNA (cffDNA) present in maternal blood. This DNA comes from the placenta and circulates freely in the maternal bloodstream.
iGene® NIPT screens for Trisomy 21 (Down Syndrome), Trisomy 18 (Edward Syndrome), Trisomy 13 (Patau Syndrome), Sex Chromosome Aneuploidies and selected Deletions.
iGene® NIPT is powered by BGI Technology
Medical treatment has to be individualised and can only be rendered after adequate assessment of your condition through appropriate clinical examination, and after discussion with your doctor. You should not rely on the information provided herein. Please note that the contents of this page are provided on the understanding that no surgical or medical advice or recommendation is being rendered.
1. Zhang et al.,Ultrasound Obstet. & Gynecol 2015